Skip to main content
eScholarship
Open Access Publications from the University of California

Tumor suppressor pathways shape EGFR-driven lung tumor progression and response to treatment

Abstract

In vivo modeling combined with CRISPR/Cas9-mediated somatic genome editing has contributed to elucidating the functional importance of specific genetic alterations in human tumors. Our recent work uncovered tumor suppressor pathways that affect EGFR-driven lung tumor growth and sensitivity to tyrosine kinase inhibitors and reflect the mutational landscape and treatment outcomes in the human disease.

Main Content
For improved accessibility of PDF content, download the file to your device.
Current View